Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 4Neoplasm Metastasis 3Melanoma 3Leukemia, Myelomonocytic, Chronic 3Breast Neoplasms 3Advanced Solid Tumor 3Recurrence 2Ovarian Neoplasms 2Lymphoma, B-Cell 2Leukemia, Monocytic, Acute 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Non-Squamous Non-small Cell Lung Cancer 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Microsatellite Instability 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

vedolizumab 1Injections 1Genetic Testing 1Gene Expression Profiling 1Gemtuzumab 1Decitabine 1Daunorubicin 1Cytarabine 1Calcineurin Inhibitors 1CPX-351 1Azacitidine 1Amplified Fragment Length Polymorphism Analysis 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myelomonocytic, Acute × Injections × Clear all
NCT01627041 2026-04-27

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
178 enrolled
Other hematologic neoplasm

Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡